 GERMANTOWN, Md.--BUSINESS WIRE--Senseonics Holdings, Inc. NYSE American: SENS, a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring CGM system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan the Plan in accordance with NYSE American Company Guide Section 711a. On July 1, 2021, Senseonics Compensation Committee granted 5 new non-executi 